PARP Inhibitors in Pancreatic Cancer: Experts Discuss Importance of Testing for Biomarkers Along With Current Treatment Landscape

From Decera Clinical Education Oncology Podcast Decera Clinical Education

Listen to Philip Agop Philip, MD, PhD, FRCP, and Elena Gabriela Chiorean, MD, discuss the role of testing for biomarkers and the current paradigm of PARP inhibitor therapy in the treatment of pancreatic cancer.

Community discussion

Join the conversation

PARP Inhibitors in Pancreatic Cancer: Experts Discuss Importance of Testing for Biomarkers Along With Current Treatment Landscape

You May Also Like

Lana Blakely

Chat GPT Questions

Chat GPT Collective Consciousness

Teach 4 the Heart

Motivational Speeches

Fluent Fiction - Korean

Fluent Fiction - Portuguese (Portugal) 🇵🇹

FluentFiction - Afrikaans

Fluent Fiction - Norwegian

Fluent Fiction - Russian